XTX Topco Ltd提高了生物技术公司的股权,使分析家对新疗法持乐观态度。
XTX Topco Ltd boosts stakes in biotech firms, drawing analyst optimism on new treatments.
XTX Topco有限公司增加了在几个生物技术公司中的股份,其中包括Tenaya治疗公司、270生物公司、TSCAN治疗公司、Larimar治疗公司和X4制药公司。
XTX Topco Ltd increased its stake in several biotech companies, including Tenaya Therapeutics, 2seventy bio, TScan Therapeutics, Larimar Therapeutics, and X4 Pharmaceuticals.
机构投资者现在拥有这些公司的很大一部分股票,许多分析家保持“买入”评级和正价目标。
Institutional investors now own significant portions of these companies' stocks, with many analysts maintaining "buy" ratings and positive price targets.
这些公司注重发展心脏病、癌症、罕见疾病和其他疾病的治疗。
These firms focus on developing treatments for heart disease, cancer, rare diseases, and other conditions.